Investigación / Grupos de investigación

Grupo  602

Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Publicaciones (896)

  • Johnston, S; Martin, M; O'Shaughnessy, J; Hegg, R; Tolaney, SM; Guarneri, V; Del Mastro, L; Campone, M; Sohn, J; Boyle, F; Cortes, J; Rugo, HS; Goetz, MP; Hamilton, EP; Huang, CS; Senkus, E; Cicin, I; Testa, L; Neven, P; Huober, J; Shao, Z; Wei, R; Munoz, M; San Antonio, B; Shahir, A; Rastogi, P; Harbeck, N.

    Overall survival with abemaciclib in early breast cancer

    ANNALS OF ONCOLOGY. 2026; 37(2): 155-165 Nº de citas: 29 [doi:10.1016/j.annonc.2025.10.005]

  • Molassiotis, A; Jordan, K; Karthaus, M; Dranitsaris, G; Roeland, EJ; Schwartzberg, L; Stimamiglio, V; Alonzi, A; Tilola, SO; Bonizzoni, E; Vázquez, EB; Buchler, T; Cheng, Y; Christoph, DC; Alfonso, PG; Lu, X; Majem, M; Mavroudis, D; Syrigos, K; Tomlins, E; Zhou, Z; Zimovjanová, M; Aapro, M.

    Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial

    ANNALS OF ONCOLOGY. 2026; 37(2): 260-270 Nº de citas: 4 [doi:10.1016/j.annonc.2025.10.017]

  • Pizarro-Gómez, C; Collado-Borrell, R; Escudero-Vilaplana, V; Massarrah, T; Revuelta-Herrero, JL; Calles, A; Alvarez, R; Villanueva-Bueno, C; Mur-Mur, A; Sánchez-Fresneda, MN; Herranz, A; Benedí-González, J; Martín, M; Sanjurjo, M.

    Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing

    JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2026; : [doi:10.1177/10781552251409387]

  • Rosa, AA; Carolina, AP; Marta, AV; Francisco, A; Adriana, FG; Natalia, G; Pablo, LL; Cristina, MF; Lydia, MS; Ulrike, N; Marina, S; Guillermo, HT; Henar, CG; Ana, GOD.

    Experience of a Referral Center with Desmoid Tumors, Part 2: A Retrospective Analysis of 109 Cases

    Cancers. 2026; 18(2): [doi:10.3390/cancers18020305]

  • López-Tarruella, S; Guerrero-Zotano, A; Antolín, S; Cruz, J; Martínez, P; Rodríguez, CA; Falo, C; Rodríguez-Lescure, A; Adrover, E; Hernández, M; Andrés, R; Chacón, JI; Romero, JLA; Miguel, A; Gómez-Raposo, C; Margelí, M; González, I; Guerra, JA; Antón, A; Tibau, A; Miralles, JJ; Escudero, MJ; Bezares, S; Rojo, F; Alvarez, I.

    Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM)

    Therapeutic Advances in Medical Oncology. 2026; 18: [doi:10.1177/17588359261421813]

  • de Andrea, CE; Abengozar-Muela, M; Arranz, JA; Climent, MA; Puente, J; Vizcay, A; de la Fuente, LM; Jurado, JM; Bonfill, T; Santander, C; Villa, JC; Pujol, E; Rosero, AC; Gomez, J; Fernández, EM; Fernández, CA; Ramirez, I; Arnáiz, P; López-Janeiro, A; Melero, I; Sanmamed, MF; Pérez-Gracia, JL.

    Association of PD-1, LAG-3 and TIM-3 expression on intratumoral CD8 T-cells with response to atezolizumab in a Real-World-Evidence biomarker study for advanced urothelial carcinoma patients

    OncoImmunology. 2025; 14(1): Nº de citas: 2 [doi:10.1080/2162402X.2025.2538687]

  • Cerezuela-Fuentes, P; Piñero-Madrona, A; Muñoz-Couselo, E; Manzano, JL; Berciano-Guerrero, MA; Majem, M; Espinosa, E; Soria, A; de Miguel, PA; Castaño, AG; Crespo, G; Sanz, LG; de la Rosa, CA; Fernández-Morales, LA; Puértolas, T; Rodríguez, JF; de la Borbolla, MR; Bellido, L; Castro, RL; Pérez, VN; Arroyo, FRG; Guzmán, JCV; Balea, BC; Hernández, B; Algarra, SM; Márquez-Rodas, I.

    Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801

    Clinical & Translational Oncology. 2025; : [doi:10.1007/s12094-025-04164-w]

  • Lopez-Jiménez, C; de Lucas, MB; de la Tabla, AGO; Alonso, NG; Arregui, M; Alvarez, R.

    Primary Cardiac Sarcomas: Clinical Characteristics, Management, and Outcomes at a Spanish National Reference Center

    Cancers. 2025; 17(24): [doi:10.3390/cancers17243947]

  • Jara, P; Ariant, M; Jiménez, R; Bringas, M; Herrero, B; Echavarría, I; Jerez, Y; Lopez-Tarruella, S; Márquez-Rodas, I; del Monte-Millán, M; Massarrah, T; de la Peña, FA; Martín, M.

    Antitumor activity of the combination of vinorelbine and gemcitabine in patients with HR + /HER2-advanced breast cancer after CDK4/6 inhibitor

    BREAST CANCER RESEARCH AND TREATMENT. 2025; 215(1): Nº de citas: 1 [doi:10.1007/s10549-025-07873-6]

  • Salazar, J; Arranz, MJ; Martin-Broto, J; Serra, M; Palmerini, E; Martínez-García, J; Juan-Ribelles, A; Andion, M; Martinez-Trufero, J; Gutiérrez, G; Echebarria-Barona, A; Vaz-Salgado, MA; Regueiro, A; Alvarez, R; Valverde, C; Luna, P; Blay, P; Sebio, A.

    VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol

    Pharmaceuticals. 2025; 18(12): [doi:10.3390/ph18121855]

  • Pino-Roson, C; Avila-Arroyo, S; Parra-Blázquez, D; Zabalgogeazcoa, MJS; Moñino, D; Lopez-González, R; Sevilla-Hernández, C; González-Blázquez, C; Martín, M; Aragonés, N.

    Breast cancer incidence and survival by subtype, stage at diagnosis and socioeconomic deprivation among young women in the Community of Madrid, Spain

    INTERNATIONAL JOURNAL OF CANCER. 2025; 158(10): 2549-2559 [doi:10.1002/ijc.70278]

  • Radosa, JC; Cobo, SLT; Dzieran, J; Glastetter, E; Chen, C; Lingohr-Smith, M; Pasupuleti, V; Brufsky, A.

    Palbociclib treatment in patients with HR+/HER2-advanced or metastatic breast cancer and visceral metastasis: A systematic literature review

    BREAST. 2025; 84: [doi:10.1016/j.breast.2025.104569]

  • Cerezuela-Fuentes, P; de la Rosa, CA; Crespo, G; Berciano-Guerrero, MA; Soria, A; Muñoz-Couselo, E; Castro, RL; Majem, M; de Miguel, PA; Manzano, JL; Bellido, L; Lecumberri, MJ; Subias, MC; Guzmán, JCV; Hernández, B; Espinosa, E; Puértolas, T; Sanz, LG; Martínez, JM; Abril, VP; Algarra, SM; Márquez-Rodas, I.

    Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study

    MELANOMA RESEARCH. 2025; 35(6): 399-408 [doi:10.1097/CMR.0000000000001062]

  • Iglesias-Perez, C; Jimenez-Fonseca, P; Robles, JL; Adrián, SG; Pérez, IF; Prado, PMD; Pérez, JR; Castro, EMD; Pedroche, CD; Herreros, MGD; Campos, MC; Blanco, ABR; Fernández, MS; Verdúguez, TQ; González, DM; Rúa, MC; Crespo, JAS; Muñoz, MN; Muñoz, A; Carmona-Bayonas, A.

    Venous thrombosis in lung cancer compared with other tumors: results from the TESEO-SEOM registry

    THROMBOSIS RESEARCH. 2025; 256: [doi:10.1016/j.thromres.2025.109525]

  • de la Peña, FA; Novoa, SA; Gregori, JG; Cortijo, LG; Carrasco, FH; Martínez, MTM; Estévez, CM; Stradella, A; Losada, MJV; Ciruelos, E.

    SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (UPDATE 2025)

    Clinical & Translational Oncology. 2025; 28(1): 105-125 Nº de citas: 1 [doi:10.1007/s12094-025-04139-x]

  • Espinosa, E; Berciano-Guerrero, MA; Muñoz-Couselo, E; Puértolas, T; Manzano, JL; Soria, A; De Miguel, PA; Crespo, G; Sanz, LG; Cerezuela-Fuentes, P; de la Rosa, CA; Majem, M; Castaño, AG; Berrocal, A; Arroyo, FRG; de la Borbolla, MR; Bellido, L; Martínez, JM; Fernández, LA; Carnicero, AM; Castro, RL; Rodríguez, AB; Lecumberri, MJ; Guzmán, JCV; Balea, BC; Rodríguez, JF; Bautista, JV; Pérez, VN; Mujika, K; Subias, MC; Hernández, B; Algarra, SM; Márquez-Rodas, I.

    Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801

    Clinical & Translational Oncology. 2025; : [doi:10.1007/s12094-025-04098-3]

  • Salgado, M; de la Camara-Gomez, J; García-Escobar, I; Alvarez-Llosa, RC; González-Villarroel, P; Garay, DF; Pàmpols-Felip, M; Guillot-Morales, M; Pelegrín-Mateo, FJ; Jimenez-Orozco, E; Sastre, J; De Castro, EM; Coma, E; Bouzas, LP; Ferrer-Pérez, AI; Mompradé-Olivé, E; Cousillas-Castiñeiras, A; Covela-Rúa, M; Rojas, M; Querol, R; Díaz, LR; Merino, M; Gil, M; Sánchez-Cánovas, M; Elías, T; Marrupe-González, D; Sánchez-Gil, B; Carmona-Campos, M; García-Ferron, M; Soria, JM; Muñoz, A.

    Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design

    BMC CANCER. 2025; 25(1): [doi:10.1186/s12885-025-14620-z]

  • Verrill, M; Lux, MP; Gligorov, J; Geisler, J; Duchnowska, R; Elsberger, B; Martin, M.

    Genomic tests to guide management of breast cancer in Europe: regulation, reimbursement, adoption, and challenges

    Future Oncology. 2025; 21(27): 3573-3583 Nº de citas: 1 [doi:10.1080/14796694.2025.2577335]